ERBB2 and breast cancer: Among these processes, the loss of NR4A1 enhances the proliferative ability of luminal BC cells, which is consistent with the suppressive role of NR4A1 in inhibiting basal-like and HER2-positive BC cells24,34, confirming the tumor-suppressive role of NR4A1 in the inhibition of BC growth.